These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 3616913)

  • 21. Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats.
    Maeda A; Goto M; Zhang J; Bennet W; Groth CG; Korsgren O; Wennberg L
    Transplantation; 2003 Apr; 75(8):1409-14. PubMed ID: 12717240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for leukotrienes in cyclosporine nephrotoxicity.
    Butterly DW; Spurney RF; Ruiz P; Griffiths R; Albrightson C; Coffman TM
    Kidney Int; 2000 Jun; 57(6):2586-93. PubMed ID: 10844628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of cyclosporine on varying segments of small-bowel grafts in the rat.
    Kimura K; Money SR; Jaffe BM
    Surgery; 1988 Jul; 104(1):64-9. PubMed ID: 3260410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine: action, pharmacokinetics, and effect in the BB rat model.
    Stiller CR; Laupacis A; Keown PA; Gardell C; Dupre J; Thibert P; Wall W
    Metabolism; 1983 Jul; 32(7 Suppl 1):69-72. PubMed ID: 6865770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of bromocriptine and cyclosporine on spontaneous diabetes in BB rats.
    Mahon JL; Gunn HC; Stobie K; Gibson C; Garcia B; Dupré J; Stiller CR
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):197-200. PubMed ID: 3381274
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetic analysis of cyclosporine in adjuvant arthritic rats.
    Pollock SH; Matthews HW; D'Souza MJ
    Drug Metab Dispos; 1989; 17(6):595-9. PubMed ID: 2575493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Establishment of a new rat model of chronic cyclosporine A nephrotoxicity].
    Sun QL; Chen YP; Rui HL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Apr; 32(2):205-9. PubMed ID: 20450554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of administration route on the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles.
    Takada K; Yoshimura H; Shibata N; Masuda Y; Yoshikawa H; Muranishi S; Yasumura T; Oka T
    J Pharmacobiodyn; 1986 Feb; 9(2):156-60. PubMed ID: 3712214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine monitoring in autoimmune and other diseases.
    Ludwin D
    Clin Biochem; 1991 Feb; 24(1):97-9. PubMed ID: 2060141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of spontaneous insulin-dependent diabetes in BB rats by administration of ciamexone.
    Kiesel U; Maruta K; Treichel U; Bicker U; Kolb H
    J Immunopharmacol; 1986; 8(3):393-406. PubMed ID: 3760592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spontaneous diabetes mellitus in the BB/W rat. Effects of glucocorticoids, cyclosporin-A, and antiserum to rat lymphocytes.
    Like AA; Anthony M; Guberski DL; Rossini AA
    Diabetes; 1983 Apr; 32(4):326-30. PubMed ID: 6832488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic profiles of cyclosporine in rats. Influence of route of administration and dosage.
    Wassef R; Cohen Z; Langer B
    Transplantation; 1985 Nov; 40(5):489-93. PubMed ID: 3877356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of spontaneous diabetes in BB rats with FK 506.
    Murase N; Lieberman I; Nalesnik M; Mintz D; Todo S; Drash AL; Starzl TE
    Lancet; 1990 Aug; 336(8711):373-4. PubMed ID: 1697397
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclosporin-induced dysmorphic changes in the BB/W rat.
    Mu L; Eastman CJ
    Lancet; 1987 Oct; 2(8565):963. PubMed ID: 2889875
    [No Abstract]   [Full Text] [Related]  

  • 35. Modulation of host defenses against pyogenic microorganisms by cyclosporine.
    Miller TE; Findon G
    Transplantation; 1986 Nov; 42(5):463-6. PubMed ID: 3787701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.
    Faulds D; Goa KL; Benfield P
    Drugs; 1993 Jun; 45(6):953-1040. PubMed ID: 7691501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporine pharmacokinetics and effect in the type I diabetic rat model.
    Brunner LJ; Iyer LV; Vadiei K; Weaver WV; Luke DR
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):287-92. PubMed ID: 2699289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FK 506 prevents spontaneous diabetes in the BB rat.
    Murase N; Lieberman I; Nalesnik M; Mintz D; Todo S; Drash AL; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):551-5. PubMed ID: 1703705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of FK 506 on spontaneous diabetes in BB rats.
    Murase N; Lieberman I; Nalesnik MA; Mintz DH; Todo S; Drash AL; Starzl TE
    Diabetes; 1990 Dec; 39(12):1584-6. PubMed ID: 1700959
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.